3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
4
Nausea
4
Fatigue
4
Hematopoietic and Lymphatic System Neoplasm
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Pain
2
Neoplasms
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Anxiety Disorders
2
Syndrome
1
Supportive Care
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Radiation Injuries
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Dyspnea
1
Disease
1
Depression
1
Cough
1
Colonic Neoplasms
1
Interventions
Temozolomide
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Radiotherapy
1
Probiotics
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Folfox protocol
1
Drug Therapy
1
Doxycycline
1
Docetaxel
1
Cryosurgery
1
Clonidine
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Second Primary
×
Acupressure
×
Clear all
NCT03313193
2019-10-11
ACT-CC
University of California, San Francisco
Phase NA
Completed
95 enrolled